{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:58:44Z","timestamp":1791910724747,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.wneu.2021.04.033","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T04:59:15Z","timestamp":1618808355000},"page":"e324-e331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Neutrophil-to-Lymphocyte Ratio Is Superior to Other Leukocyte-Based Ratios as a Prognostic Predictor in Non\u2013Small Cell Lung Cancer Patients with Radiosurgically Treated Brain Metastases Under Immunotherapy or Targeted Therapy"],"prefix":"10.1016","volume":"151","author":[{"given":"Anna","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Kranawetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Untersteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farjad","family":"Khalaveh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"R\u00f6ssler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Z\u00f6chbauer-M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Gatterbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian J.","family":"Hochmair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josa M.","family":"Frischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.wneu.2021.04.033_bib1","doi-asserted-by":"crossref","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.wneu.2021.04.033_bib2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijrobp.2007.06.074","article-title":"A\u00a0new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database","volume":"70","author":"Sperduto","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2021.04.033_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2021.04.033_bib4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0360-3016(99)00549-0","article-title":"Radiosurgery for brain metastases: A score index for predicting prognosis","volume":"46","author":"Weltman","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2021.04.033_bib5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaoncol.2016.3834","article-title":"Estimating survival in patients with lung cancer and brain metastases: An update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)","volume":"3","author":"Sperduto","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.wneu.2021.04.033_bib6","first-page":"433","article-title":"Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis","volume":"127","author":"Mitsuya","year":"2017","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2021.04.033_bib7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.wneu.2021.04.033_bib8","doi-asserted-by":"crossref","first-page":"e0184412","DOI":"10.1371\/journal.pone.0184412","article-title":"Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis","volume":"12","author":"Jin","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.wneu.2021.04.033_bib9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.21037\/tlcr.2019.11.16","article-title":"Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): Neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)","volume":"8","author":"Mandaliya","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.wneu.2021.04.033_bib10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","article-title":"Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer","volume":"89","author":"Forrest","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.wneu.2021.04.033_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-020-03660-z","article-title":"Pre-radiosurgery leucocyte ratios and modified Glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients","volume":"151","author":"Cho","year":"2021","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2021.04.033_bib12","doi-asserted-by":"crossref","first-page":"23893","DOI":"10.1038\/srep23893","article-title":"Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: Evidence from 3,430 patients","volume":"6","author":"Gu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2021.04.033_bib13","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1038\/srep12493","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: A meta-analysis","volume":"5","author":"Gu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.wneu.2021.04.033_bib14","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1002\/cam4.3021","article-title":"Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy: A retrospective cohort study","volume":"9","author":"Gatterbauer","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.wneu.2021.04.033_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.wneu.2016.07.038","article-title":"Evaluation of dose-staged Gamma Knife radiosurgical treatment method for high-risk brain metastases","volume":"94","author":"Frischer","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.wneu.2021.04.033_bib16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3389\/fonc.2020.00654","article-title":"Pretreatment neutrophil-to-lymphocyte ratio (NLR) may predict the outcomes of advanced non-small-cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs)","volume":"10","author":"Li","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2021.04.033_bib17","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.4049\/jimmunol.0902583","article-title":"Inflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillance","volume":"185","author":"Augier","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.wneu.2021.04.033_bib18","doi-asserted-by":"crossref","first-page":"e18607","DOI":"10.1097\/MD.0000000000018607","article-title":"Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer","volume":"99","author":"Huang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.wneu.2021.04.033_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/JTO.0000000000000399","article-title":"Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer","volume":"10","author":"Cannon","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.wneu.2021.04.033_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1080\/07357907.2016.1213276","article-title":"Prognostic significance of the preoperative lymphocyte to monocyte ratio in patients with stage I non-small cell lung cancer undergoing complete resection","volume":"34","author":"Xia","year":"2016","journal-title":"Cancer Invest"},{"key":"10.1016\/j.wneu.2021.04.033_bib21","doi-asserted-by":"crossref","first-page":"e21718","DOI":"10.1097\/MD.0000000000021718","article-title":"The prediction potential of neutrophil-to-lymphocyte ratio for the therapeutic outcomes of programmed death receptor-1\/programmed death ligand 1 inhibitors in non-small cell lung cancer patients: A meta-analysis","volume":"99","author":"Huang","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.wneu.2021.04.033_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11060-018-2914-5","article-title":"Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery","volume":"139","author":"Chowdhary","year":"2018","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2021.04.033_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s11060-020-03477-w","article-title":"Pre-stereotactic radiosurgery neutrophil-to-lymphocyte ratio is a predictor of the prognosis for brain metastases","volume":"147","author":"Zhang","year":"2020","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2021.04.033_bib24","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.3390\/cancers12123668","article-title":"Gamma Knife radiosurgery for brain metastases in non-small cell lung cancer patients treated with immunotherapy or targeted therapy","volume":"12","author":"Cho","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.wneu.2021.04.033_bib25","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1245\/s10434-015-4518-z","article-title":"The platelet-to-lymphocyte ratio versus neutrophil-to-lymphocyte ratio: Which is better as a prognostic factor in gastric cancer?","volume":"22","author":"Kim","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.wneu.2021.04.033_bib26","doi-asserted-by":"crossref","first-page":"106677","DOI":"10.1016\/j.intimp.2020.106677","article-title":"Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis","volume":"85","author":"Zhang","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.wneu.2021.04.033_bib27","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/1759-7714.12815","article-title":"Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis","volume":"9","author":"Tan","year":"2018","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.wneu.2021.04.033_bib28","doi-asserted-by":"crossref","first-page":"e11648","DOI":"10.1097\/MD.0000000000011648","article-title":"The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs","volume":"97","author":"Zhang","year":"2018","journal-title":"Medicine (Baltimore)"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021005738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875021005738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:58:54Z","timestamp":1761814734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875021005738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":28,"alternative-id":["S1878875021005738"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2021.04.033","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophil-to-Lymphocyte Ratio Is Superior to Other Leukocyte-Based Ratios as a Prognostic Predictor in Non\u2013Small Cell Lung Cancer Patients with Radiosurgically Treated Brain Metastases Under Immunotherapy or Targeted Therapy","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2021.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}